Soleno Therapeutics Inc Sustainability Reports
A biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of rare diseases, primarily offering its sole therapeutic product VYKAT XR for Prader-Willi syndrome.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493003LCY77N7FXK844
FIGI: BBG0024L5B95
6 reports from 2017 to 2024